SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2018

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]

Supplemental Information, Balance Sheets

Balance sheets:

	December 31,
(U.S. dollars in thousands)	2017		2018
a.     Other assets:
Institutions	$	394	$	574
State of Israel (see note 6a)		195		190
Restricted deposit		623		561
Prepaid expenses		433		453
Assets of discontinued operation		215
Sundry		74		99
	$	1,934	$	1,877

	December 31,
(U.S. dollars in thousands)	2017		2018
b.     Accounts payable and accruals – other:
Payroll and related expenses	$	1,386	$	1,099
Interest payable		645		555
Provision for vacation		1,650		1,658
Accrued expenses		4,802		6,368
Royalties payable		301		369
Property and equipment suppliers		526		225
	$	9,310	$	10,274

Supplemental Information, Statements of Operations

Statements of operations:

	December 31,
(U.S. dollars in thousands)	2016		2017		2018
Revenues from selling goods:
Pfizer	$	5,226	$	12,181	$	5,320
Brazil	$	3,973	$	7,061	$	3,658
	$	9,199	$	19,242	$	8,978
Revenue from license and R&D services			$	1,836	$	25,262